The war in Ukraine will have direct and indirect health consequences on conflict affected people, including internally displaced people and refugees. Governments in countries receiving refugees are providing them with access to healthcare. This document aims to provide information to guide individua...l health assessment carried out by frontline health providers at border areas, reception centres, transit centres and individual clinics as well as national public health agencies/authorities in countries receiving refugees and third country nationals.
more
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,... which constitutes one of the elements of the WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce, through the assessment of applications for manufacturing authorizations and as a basis for the inspection of manufacturing facilities. It may also be used as training material for government medicines inspectors, as well as for production, QC and QA personnel in the industry
more
Annex of Environmental Health in Emergencies and Disaster; page 245 - 252
Information in Tables 1–4 summarizes the actions of the World Health Organization,
the International Atomic Energy Authority, other international organizations, and local
health authorities in response to a nuclear acci...dent, in compliance with the Convention
on Early Notification and the Assistance Convention.
more
Under the International Health Regulations (IHR) 2005, public health authorities at international ports, airports and ground crossings are required to establish effective contingency plans and arrangements for responding to events that may constitute a public health emergency of international concer...n and to communicate with their National IHR Focal Point about relevant public health measures.
The current outbreak of novel coronavirus (COVID-19) disease has spread across borders through travelers, conveyances, which has prompted demands for the detection and management of suspected cases at points of entry (POE), including ports, airports and ground crossings, on board conveyances.
more
10 July 2020
Guidance for authorities and event organizers planning mass gatherings during the current COVID-19 pandemic
The content of this Risk Assessment tool has been updated to reflect new WHO guidance and new evidence on both COVID-19 and mass gatherings, as well as feedback from end-users.
...
Additional improvements have been made to the way the information is organized and presented: the Decision Tree is now built into the tool and a new tab dedicated to Risk Communication has been added. The expanded tool now includes six tabs: 1. Instructions; 2. Decision Tree; 3. Risk Evaluation; 4. Risk Mitigation; 5. Decision Matrix; 6. Risk Communication.
more
The COVID-19 Supply Portal is a purpose-built tool to facilitate national authorities and all implementing partners supporting COVID-19 National Action Plans to request critical supplies.
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its fro...ntiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
more
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities,
or concerning the delimitation of its fr...ontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
more
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorites, or
concerning the delimitation of its f...rontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
more
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...f herbal medicine in this part of the world and the corresponding need for mechanisms to ensure that these products are safe and effective, yet remain broadly accessible. With this need in mind, the report sets out a comprehensive framework for developing national policies designed to control the safety, efficacy, and quality of herbal medicines, manufacturing practices, product registration, and labelling, marketing, and trade.
more
COVID-19 poses challenges in places of detention, given the specific vulnerabilities of detainees and difficulty of containing outbreaks in such settings. The ICRC's approach to COVID-19 in detention is anchored in support to the authorities who are primarily and ultimately responsible for the wellb...eing of detainees and staff.
In the context of a public health crisis, it is crucial to ensure good communication with detainees, staff and visitors on the scale of the pandemic and the measures taken to prevent its spread.
The ICRC has produced three sensitization and training videos for use by detaining authorities and for all in the wider public who may be affected by detention, such as families of detainees. Using an existing virtual prison environment, the recommended response of a fictional detaining authority is portrayed.
more
he health authorities in the Democratic Republic of the Congo today declared an outbreak of Ebola after a case was confirmed in Mbandaka, a city in the north-western Equateur Province. This is the third outbreak in the province since 2018.
As vaccines get approved by national authorities, learn about National and WHO approval processes for vaccines and how safety is ensured during emergency approval of vaccines. Dr Mariângela Simão explains in Science in 5.
The Ministry of Public Health in the Democratic Republic of the Congo (DRC) has reported the country’s first case of COVID-19. Health authorities said tests found that a Congolese national, who had recently returned to Kinshasa from his residence in France had tested positive for the virus.
At the end of this course, you should be able to:
- draft an airport public health contingency plan for managing COVID-19 cases and outbreaks in aviation;
- manage an outbreak of COVID-19 disease in aviation.
Target audience:
- National IHR Focal Points (NFPs)
- Airport health authorities and... local, provincial, and national health surveillance and response systems
- Civil aviation authorities, airport operators, aircraft operators, airports, and airlines
more
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...is also provided to standardize monitoring and public reporting of variant circulation.
The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variants
more
Version 3 Dec. 2020
The COVID-19 Vaccine Introduction Readiness Assessment Tool (VIRAT)2, developed by WHO in collaboration with PAHO is a tool for the national authorities, that allows for the establishment of a roadmap and to monitor progress in the preparation of the activities related to the in...troduction of the COVID-19 vaccines.
more
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ...the efficiency of assessment, review and authorizations of medical products. Vaccines are undoubtedly the most complex medical products to develop, from concept to a stage where sufficient evidence of quality, safety and efficacy are collected to provide an assurance that their use will provide more benefits than risks when used in the context of a public health emergency.
more
Food inspection is crucial for ensuring food safety, using risk-based approaches to target high-risk products and businesses. This guidance aids national authorities in designing and implementing risk-based systems, offering step-by-step instructions, examples, and tools for prioritization and inspe...ction frequency estimation. It emphasizes adapting to individual country needs and recognizing variations in food risks and production chain characteristics. The document underscores resource-efficient, risk-based food inspection systems, prioritizing high-risk products and businesses to prevent safety incidents proactively. It suggests designing models based on relevant information and periodically adjusting them for continuous improvement.
more